Officials said over 71,000 Oklahomans are currently living with Alzheimer's disease. Nationally, that number is approaching 7 ...

Annovis Bio, Inc. (NYSE: ANVS) announced its financial results for the third quarter ending September 30, 2024, alongside ...

An 80-something patient came in for an annual visit recently and was worried that recent memory lapses might be symptoms of ...

With Eisai and Biogen’s Leqembi and Eli Lilly’s Kisunla launching onto the market, the 2024 Clinical Trials of Alzheimer’s ...

And also we found the significant effects in terms of ADAS-Cog [Alzheimer's Disease Assessment Scale-Cognitive Subscale], ...

Some researchers seek to establish a single abnormal result on a set of biomarker-based tests as sufficient to diagnose the ...

In a small early trial using a transcranial magnetic stimulation procedure, scientists were able to target a key brain ...

November is Alzheimer's Awareness Month, and if you have a loved one in the beginning stages of the disease, a local clinical ...

Researchers at Texas A&M University have developed a nasal spray shown to delay disease progression in animals -- fueling hope it could one day work in humans.

In the effort to expand approaches to treating Alzheimer’s beyond targeting amyloid, some companies have sought to target ...

Trajectories of frailty increased more rapidly 4 to 9 years before dementia onset. Even before this acceleration, higher ...

Roche recently presented data at the 17th Clinical Trials in Alzheimer’s Disease congress (CTAD) on two new Alzheimer’s disease blood tests currently in development. Both tests reportedly show ...